HomeBLTE • NASDAQ
add
Belite Bio Inc
Previous close
$90.37
Day range
$88.12 - $92.11
Year range
$49.00 - $92.11
Market cap
3.20B USD
Avg Volume
65.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
The Globe and Mail
21 hours ago
TSX falls the most in six months as gold slides and inflation heats up
1.73%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.47M | 0.00% |
Net income | -9.49M | 0.00% |
Net profit margin | — | — |
Earnings per share | -0.50 | -61.29% |
EBITDA | -10.43M | 0.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 156.41M | 32.07% |
Total liabilities | 6.52M | 69.98% |
Total equity | 149.88M | — |
Shares outstanding | 32.60M | — |
Price to book | 19.65 | — |
Return on assets | -16.33% | — |
Return on capital | -17.00% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.49M | 0.00% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2016
Website
Employees
25
